MarketPulse — Real-Time Financial News & Market Analysis

Soleno Therapeutics faces class action lawsuit alleging material safety concerns about DCCR drug were hidden from investors. Lead plaintiff deadline is May 5, 2026.

Angelo Gordon invested $31.6M in Quanex Building Products amid quarterly losses, with the stock surging 15% year-to-date, signaling contrarian conviction on housing recovery.

Oracle surged 9% on Q3 earnings beat: $17.2B revenue (+22%), cloud revenue jumped 84%, AI infrastructure soared 243%. Fiscal 2027 guidance projects $90B revenue.

BellRing Brands faces securities class action alleging material disclosure failures from November 2024–August 2025, with stock declines of 19% and 33% following disappointing guidance.

Tesla and Rivian face EV market headwinds, but Tesla's diversified business and stronger execution give it an edge over the luxury EV startup for long-term investors.

Schall Law Firm recruits investors in $CWH securities fraud lawsuit alleging false inventory and demand statements, seeking class representatives for April 2025-February 2026 period.

Three renewable energy stocks offer buy-and-hold opportunities: Brookfield Renewable for pure clean energy exposure, NextEra Energy for conservative dividend-growth investors, TotalEnergies for pragmatic transition positioning.

Securities class action filed against PayPal for allegedly misleading investors on revenue outlook. Stock fell over 20% after disappointing February 2026 earnings and unachievable 2027 targets.

Driven Brands Holdings faces class action securities fraud lawsuit over lease accounting errors that allegedly overstated revenue and cash from 2023-2024.

Rosen Law Firm sued Richtech Robotics for allegedly misrepresenting a Microsoft partnership. Investors must file claims by April 3, 2026.

Rosen Law Firm notifies $CORT investors of securities class action alleging misrepresentation of clinical trial data for relacorilant drug and undisclosed FDA concerns.

Rosen Law Firm files securities class action against Franklin BSP Realty Trust alleging false statements. Investors must act before lead plaintiff deadline.

$UBER fell 12% in three months despite 22% growth and surging free cash flow, as autonomous vehicle competition from Waymo, Tesla, and Amazon's Zoox weighs on investors' long-term outlook.

Nektar Therapeutics faces securities class action over alleged misstatements about REZOLVE-AA trial, with stock falling 7.77% after trial failure announcement.

NuScale stock plunged 79% to $12 despite NRC certification, facing execution risks and $6B in contingent partnership obligations before generating material revenue.

Quantum BioPharma revises debenture offering terms following share price decline, lowering conversion price to $3.00 and increasing warrant allocation.

Robbins LLP launches class action against $SLNO over alleged investor deception regarding DCCR drug safety and efficacy for Prader-Willi syndrome treatment.

Rosen Law Firm urges Endeavor Group Holdings investors to secure counsel before March 18 deadline in securities class action over alleged false SEC filings.

Law firm Johnson Fistel investigates Netskope's $652.6M operating loss in FY2026, more than double prior year, amid revenue expansion.

Grocery Outlet ($GO) stock plunged 27.9% after announcing 36 store closures due to overexpansion, triggering a securities fraud investigation and shareholder litigation.